Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/7/2025

Post-Operative Management of Adrenal Insufficiency After Adrenalectomy for Cushing Syndrome

Immediate Perioperative Management

  • The American College of Surgeons recommends stress-dose hydrocortisone at surgery and immediately postoperatively for patients with Cushing syndrome due to adrenal adenoma, as removal of the adenoma results in tertiary adrenal insufficiency 1, 2.
  • For pediatric patients, the Endocrine Society suggests hydrocortisone 2 mg/kg at induction, followed by continuous IV infusion based on weight (25-150 mg/24 hours depending on weight and pubertal status) 1.

Post-Operative Tapering Strategy

  • The American Association of Clinical Endocrinologists recommends doubling the usual oral hydrocortisone doses for 48 hours, then reducing to normal replacement doses over up to a week 1.
  • The European Society of Endocrinology suggests continuing physiologic replacement doses (typically 15-25 mg hydrocortisone daily in divided doses) until HPA axis recovery is documented 1.
  • Serial morning cortisol monitoring is essential to guide steroid tapering and assess HPA axis recovery, as recommended by the American College of Endocrinology 1.

Stress-Dose Coverage During Recovery

  • The Anaesthesia society recommends stress-dose coverage during intercurrent illness, trauma, or subsequent surgery until HPA axis recovery is confirmed 1, 3.
  • Patients should be educated on "sick day rules" (doubling steroid doses during illness) and carry emergency hydrocortisone, as suggested by the American College of Emergency Physicians 3.

Monitoring Strategy

  • Regular endocrine follow-up during the recovery phase should assess signs of adrenal insufficiency requiring dose adjustment, as recommended by the Endocrine Society 1.
  • Morning cortisol levels should be monitored to guide tapering and eventual discontinuation, as suggested by the American Association of Clinical Endocrinologists 1.